Surgery Partners, Inc.
US ˙ NasdaqGS ˙ US86881A1007

SecuritySGRY / Surgery Partners, Inc.
InsiderMarissa Brittenham
This page shows the track record and history of Brittenham Marissa insider trades in Surgery Partners, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Marissa Brittenham in SGRY / Surgery Partners, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SGRY / Surgery Partners, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Marissa Brittenham in SGRY / Surgery Partners, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2026-03-13 3,657 12.5400 3,657 12.5400 45,859 14 11.4900 -3,839 -8.37
2026-03-06 8,785 13.7000 8,785 13.7000 120,354
2025-03-10 3,156 24.0900 3,156 24.0900 76,028
2025-02-07 14,700 25.6100 14,700 25.6100 376,467
2024-03-04 1,284 30.1700 1,284 30.1700 38,738
2024-02-02 1,637 31.8900 1,637 31.8900 52,204
2023-02-02 1,320 35.9000 1,320 35.9000 47,388

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SGRY / Surgery Partners, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-03-16 2026-03-13 4 Brittenham Marissa SGRY Common Stock S - Sale D 12.5400 -3,657 -46 94,196
2026-03-09 2026-03-06 4 Brittenham Marissa SGRY Common Stock S - Sale D 13.7000 -8,785 -120 54,623
2026-03-09 2026-03-05 4 Brittenham Marissa SGRY Common Stock A - Award D 14.1100 9,150 129 97,853
2026-03-09 2026-03-05 4 Brittenham Marissa SGRY Common Stock A - Award D 14.1100 16,363 231 88,703
2026-03-09 2026-03-05 4 Brittenham Marissa SGRY Common Stock A - Award D 14.1100 17,717 250 72,340
2025-03-13 2025-03-10 4 Brittenham Marissa SGRY Common Stock S - Sale D 24.0900 -3,156 -76 63,408
2025-03-06 2025-03-04 4 Brittenham Marissa SGRY Common Stock A - Award D 23.8000 6,302 150 66,564
2025-03-06 2025-03-04 4 Brittenham Marissa SGRY Common Stock A - Award D 23.8000 10,084 240 60,262
2025-02-10 2025-02-07 4 Brittenham Marissa SGRY Common Stock S - Sale D 25.6100 -14,700 -376 50,178
2025-02-04 2025-01-31 4 Brittenham Marissa SGRY Common Stock A - Award D 25,110 64,878
2024-03-06 2024-03-04 4 Brittenham Marissa SGRY Common Stock S - Sale D 30.1700 -1,284 -39 39,768
2024-03-01 2024-02-28 4 Brittenham Marissa SGRY Common Stock A - Award D 31.1800 7,697 240 41,052
2024-03-01 2024-02-28 4 Brittenham Marissa SGRY Common Stock A - Award D 31.1800 2,886 90 33,355
2024-02-06 2024-02-02 4 Brittenham Marissa SGRY Common Stock S - Sale D 31.8900 -1,637 -52 30,469
2023-03-06 2023-03-02 4 Brittenham Marissa SGRY Common Stock A - Award D 32.8600 15,216 500 32,106
2023-03-06 2023-03-02 4 Brittenham Marissa SGRY Common Stock A - Award D 32.8600 7,608 250 16,890
2023-02-06 2023-02-02 4 Brittenham Marissa SGRY Common Stock S - Sale D 35.9000 -1,320 -47 9,282
2022-02-03 2022-02-01 4 Brittenham Marissa SGRY Common Stock A - Award D 44.8000 10,602 475 10,602
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)